Webcast replay
Recorded on 26th April 2023 at 12pm (AEST).
Professional traders Steven Yatomi-Clarke share their thoughts on what exactly is happening to the market, what might happen next, and how the current conditions compare with previous periods.
Recorded on 26th April 2023 at 12pm (AEST).
Contact me about this company 
Browse upcoming webcasts (AEST)
Prescient Therapeutics (ASX: PTX) CEO and MD Steven Yatomi-Clarke discusses how Prescient’s broad portfolio of well advanced assets developed with world-leading partners including Yale, UPenn, Oxford, MDAnderson & Peter MacCallum.
Feature Speakers
STEVEN YATOMI-CLARKE
CEO and Managing Director
Steven took over as CEO of Prescient Therapeutics in 2016 and has overseen its progression from start-up phase. Steven manages a team in Australia and the US and has been instrumental in strategy development; licensing; initiating and managing clinical trials; fundraising and business development. He has been a collaborator on various immunotherapy research projects.
